Pharmaceutics,
Год журнала:
2023,
Номер
15(10), С. 2406 - 2406
Опубликована: Сен. 30, 2023
The
main
concept
of
radiosensitization
is
making
the
tumor
tissue
more
responsive
to
ionizing
radiation,
which
leads
an
increase
in
potency
radiation
therapy
and
allows
for
decreasing
dose
concomitant
side
effects.
Radiosensitization
by
metal
oxide
nanoparticles
widely
discussed,
but
range
mechanisms
studied
not
sufficiently
codified
often
does
reflect
ability
nanocarriers
have
a
specific
impact
on
cells.
This
review
focused
magnetic
iron
while
they
occupied
special
niche
among
prospective
radiosensitizers
due
unique
physicochemical
characteristics
reactivity.
We
collected
data
about
possible
molecular
underlying
radiosensitizing
effects
(IONPs)
approaches
their
therapeutic
efficacy
variable
modifications.
Pharmaceutics,
Год журнала:
2023,
Номер
15(1), С. 236 - 236
Опубликована: Янв. 10, 2023
Despite
significant
advances
in
cancer
therapy
over
the
years,
its
complex
pathological
process
still
represents
a
major
health
challenge
when
seeking
effective
treatment
and
improved
healthcare.
With
advent
of
nanotechnologies,
nanomedicine-based
has
been
widely
explored
as
promising
technology
able
to
handle
requirements
clinical
sector.
Superparamagnetic
iron
oxide
nanoparticles
(SPION)
have
at
forefront
nanotechnology
development
since
mid-1990s,
thanks
their
former
role
contrast
agents
for
magnetic
resonance
imaging.
Though
use
MRI
probes
discontinued
due
an
unfavorable
cost/benefit
ratio,
several
innovative
applications
therapeutic
tools
prompted
renewal
interest.
The
unique
characteristics
SPION,
i.e.,
properties
enabling
specific
response
submitted
high
frequency
(magnetic
hyperthermia)
or
low
(magneto-mechanical
therapy)
alternating
field,
ability
generate
reactive
oxygen
species
(either
intrinsically
activated
using
various
stimuli),
make
them
particularly
adapted
therapy.
This
review
provides
comprehensive
description
fundamental
aspects
SPION
formulation
highlights
recent
approaches
regarding
vivo
field
Advanced Materials,
Год журнала:
2023,
Номер
35(51)
Опубликована: Июнь 1, 2023
Sonodynamic
therapy
(SDT)
is
a
promising
non-invasive
therapeutic
modality
to
treat
deep-seated
tumors
owing
the
good
tissue
penetration
ability
and
spatiotemporal
controllability
of
ultrasound
(US);
however,
low
sonodynamic
activity
potential
side
effects
greatly
limit
its
clinical
translation.
Cancer
immunotherapy
that
leverages
immune
system
fight
against
cancer
has
great
synergize
with
SDT
for
treatment
high
efficiency
safety.
In
this
review,
convergence
exert
their
merits
break
through
limitations
combination
sono-immunotherapy
are
discussed.
The
focus
on
development
construction
organic
materials
immunotherapeutic
efficiency.
These
not
only
induce
immunogenic
cell
death
improve
tumor
immunogenicity
via
but
also
activate
antitumor
immunity
immuno-oncology
drug-mediated
pathway
modulation.
various
drugs
sonosensitizers
categorized
discussed
along
prospects
challenges
ACS Nano,
Год журнала:
2022,
Номер
16(4), С. 5943 - 5960
Опубликована: Март 22, 2022
The
development
of
bacterial
vaccines
for
inducing
an
immunoresponse
against
infectious
diseases
such
as
osteomyelitis
is
great
significance
and
importance.
However,
the
responsiveness
immunotherapy
remains
far
from
being
satisfactory,
largely
due
to
erratic
antigen
epitopes
bacteria.
Herein,
we
report
in
situ
vaccination
strategy
infection
based
on
model
using
a
biomimetic
nanomedicine
named
HMMP,
which
was
constructed
by
engineering
PpIX-encapsulated
hollow
MnOx
with
hybrid
membrane
exfoliated
both
macrophage
tumor
cell
lines.
as-established
HMMP
features
burst
release
vaccine
augmented
sonodynamic
treatment
resultant
priming
antigen-presenting
cells
following
activations
cellular
humoral
adaptive
immunities
infections.
This
regimen
not
only
triggers
initial
regression
established
but
also
simultaneously
generates
robust
systemic
antibacterial
immunity
poorly
immunogenic
secondary
contralateral
knee
additionally
confers
long-lasting
bacteria-specific
immune
memory
responses
prevent
relapse.
Thus,
our
study
provides
proof
concept
activation
innate
responses,
providing
individual-independent
immunotherapy.
Journal of the American Chemical Society,
Год журнала:
2023,
Номер
145(7), С. 3952 - 3960
Опубликована: Фев. 9, 2023
The
complexity,
diversity,
and
heterogeneity
of
malignant
tumors
pose
a
formidable
challenge
for
antitumor
therapy.
To
achieve
the
goal
significantly
enhancing
effect,
nanomedicine-based
synergistic
therapy
is
one
important
strategies.
Herein,
we
innovatively
report
defect-rich
glassy
IrTe2
(G-IrTe2)
with
weak
Ir–Te
bond
strength
sonodynamic
(SDT),
chemodynamic
(CDT),
mild
photothermal
(PTT).
G-IrTe2
sonosensitizer
under
ultrasound
(US)
stimuli
exhibits
excellent
reactive
oxygen
species
(ROS)
production
performance.
Besides,
catalase
(CAT)-like
activity
can
provide
abundant
to
enhance
SDT
effect.
Then,
theoretical
calculation
verifies
that
US
easily
make
irregular
be
broken
in
amorphous
free
electrons
will
released
combine
further
form
singlet
(1O2).
Meanwhile,
peroxidase
(POD)-like
also
catalyze
endogenous
H2O2
produce
more
ROS
which
conducive
better
tumor
ablation.
Furthermore,
produced
by
sono-/chemodynamic
processes
cause
mitochondrial
dysfunction
give
rise
heat
shock
protein
(HSP)
downregulated
expression,
maximizing
efficiency
PTT.
Therefore,
such
rich
defect
could
involved
oncotherapy
then
effectively
outstanding
efficacy.
This
study
provides
new
research
idea
expanding
application
inorganic
nanomaterials
promoting
therapeutic
effect
tumors.
Cancers,
Год журнала:
2024,
Номер
16(6), С. 1156 - 1156
Опубликована: Март 14, 2024
Hyperthermia
(HT)
is
an
anti-cancer
therapy
commonly
used
with
radio
and
chemotherapies
based
on
applying
heat
(39-45
°C)
to
inhibit
tumor
growth.
However,
controlling
towards
tumors
not
normal
tissues
challenging.
Therefore,
nanoparticles
(NPs)
are
in
HT
apply
only
induce
DNA
damage
the
expression
of
shock
proteins,
which
eventually
result
apoptosis.
The
aim
this
review
article
summarize
recent
advancements
use
magnetic
NPs
locally
increase
temperature
promote
cell
death.
In
addition,
development
nanocarriers
as
NP-based
drug
delivery
systems
discussed.
Finally,
efficacy
combined
chemotherapy,
radiotherapy,
gene
therapy,
photothermal
immunotherapy
explored.
Journal of the American Chemical Society,
Год журнала:
2024,
Номер
146(15), С. 10217 - 10233
Опубликована: Апрель 2, 2024
Although
immunotherapy
is
relatively
effective
in
treating
hematological
malignancies,
their
efficacy
against
solid
tumors
still
suboptimal
or
even
noneffective
presently.
Compared
to
cancers,
exhibit
strikingly
different
immunosuppressive
microenvironment,
severely
deteriorating
the
of
immunotherapy:
(1)
chemical
features
such
as
hypoxia
and
mild
acidity
suppress
activity
immune
cells,
(2)
pro-tumorigenic
domestication
cells
microenvironment
within
further
undermines
effectiveness
immunotherapy,
(3)
dense
physical
barrier
tumor
tissues
prevents
intratumoral
infiltration
contact
killing
active
cells.
Therefore,
we
believe
that
reversing
are
critical
priority
for
tumors.
Due
unique
morphologies,
structures,
compositions,
nanomedicines
have
become
powerful
tools
achieving
this
goal.
In
Perspective,
will
first
briefly
introduce
then
summarize
most
recent
progresses
nanomedicine-based
by
remodeling
immune-microenvironment
a
comprehensive
manner.
It
highly
expected
Perspective
aid
advancing
tumors,
optimistic
on
future
development
burgeoning
field.
ACS Nano,
Год журнала:
2023,
Номер
17(12), С. 11384 - 11395
Опубликована: Июнь 8, 2023
Pancreatic
cancer,
with
extremely
limited
treatment
options
and
poor
prognosis,
urgently
needs
a
breakthrough
in
early
diagnosis
monitoring.
Tumor
exosomes
(T-Exos)
detection
is
presently
one
of
the
most
clinically
significant
liquid
biopsy
approaches
for
non-invasive
pancreatic
cancer
diagnosis,
which,
unfortunately,
cannot
be
applied
as
routine
diagnostic
tool
until
number
obstacles,
such
unsatisfactory
specificity
sensitivity,
well
labor-intensive
purification
analysis
procedures
by
ultracentrifugation
enzyme-linked
immunosorbent
assay,
are
overcome.
Here,
we
report
facile
nanoliquid
assay
especially
specific,
ultrasensitive
yet
economical
T-Exos
dual
specific
biomarker
antigen
co-recognition
capturing
strategy,
which
enabled
grafting
two
corresponding
capture
antibodies
on
magnetic
nanoparticles
gold
nanoparticles,
accurate
target
tumor
exosomes.
This
approach
exhibits
excellent
ultrahigh
sensitivity
detecting
low
78
pg/mL
exosome
protein
GPC1.
Successful
screening
21
samples
from
22
normal
control
cases
enhanced
ensures
promising
monitoring
stage
cancer.